top of page
Oct 2024
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States
Xiao Zang, Alexandra Skinner, Zongbo Li, Leah C Shaw, Czarina N Behrends, Avik Chatterjee, Ali Jalali, Ashly E Jordan, Jake R Morgan, Shayla Nolen, Bruce R Schackman, Brandon D L Marshall, Alexander Y Walley
Addiction
Apr. 2024
The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US
Christina E Freibott, Ali Jalali, Sean M Murphy, Alexander Y Walley, Benjamin P Linas, Philip J Jeng, Jeffrey Bratberg, Brandon D L Marshall, Xiao Zang, Traci C Green, Jake R Morgan
J Am Pharm Assoc
Sep. 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
Juliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R Schackman, Jianing Wang, R W M A Madushani, Jake R Morgan, Joshua A Barocas, Alexander Y Walley, Stavroula A Chrysanthopoulou, Benjamin P Linas, Sabrina A Assoumou
JAMA Netw Open.
Apr. 2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, Alexandria Macmadu, R W M A Madushani, Ruth A Potee, Danielle Ryan, Sean M Murphy, Alexander Y Walley, Benjamin P Linas
JAMA Netw Open.
Nov 2022
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study
Allison R David, Carlos R Sian, Christina M Gebel, Benjamin P Linas, Jeffrey H Samet, Linda S Sprague Martinez, Jordana Muroff, Judith A Bernstein, Sabrina A Assoumou
J Subst Abuse Treat.
Oct. 2022
Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs
Joëlla W Adams, Alexandra Savinkina, Aaron Fox, Czarina N Behrends, Rajapaksha W M A Madushani, Jianing Wang, Avik Chatterjee, Alexander Y Walley, Joshua A Barocas, Benjamin P Linas
Addiction.
Sep. 2022
Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis
Alexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, Jianing Wang, Joshua A Barocas, Jake R Morgan, Sabrina A Assoumou, Alexander Y Walley, Benjamin P Linas, Sean M Murphy
Addiciton.
Sep. 2022
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City
Jake R Morgan, Christina E Freibott, Ali Jalali, Philip J Jeng, Alexander Y Walley, Avik Chatterjee, Traci C Green, Michelle L Nolan, Benjamin P Linas, Brandon D L Marshall, Sean M Murphy
Drug Alcohol Depend Rep.
Mar. 2022
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design
Jake R Morgan, Emily K Quinn, Christine E Chaisson, Elizabeth Ciemins, Nikita Stempniewicz, Laura F White, Benjamin P Linas, Alexander Y Walley, Marc R LaRochelle
Med Care.
bottom of page